Evaluation of Experiments with Adaptive Interim Analyses
From MaRDI portal
Publication:4844280
DOI10.2307/2533441zbMath0825.62789OpenAlexW2331139255WikidataQ52364596 ScholiaQ52364596MaRDI QIDQ4844280
Publication date: 28 November 1995
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2533441
Nonparametric hypothesis testing (62G10) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Related Items
Optimal Conditional Error Functions for the Control of Conditional Power ⋮ Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials ⋮ Unnamed Item ⋮ Unnamed Item ⋮ Unnamed Item ⋮ Finite-Sample Two-Group Composite Hypothesis Testing via Machine Learning ⋮ Longitudinal clinical trials with adaptive choice of follow‐up time ⋮ SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION ⋮ An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size ⋮ A note on the shape of sample size functions of optimal adaptive two-stage designs ⋮ Adaptive designs for subpopulation analysis optimizing utility functions ⋮ Unnamed Item ⋮ A simulation program for adaptive two stage designs. ⋮ Adaptive enrichment designs with a continuous biomarker ⋮ Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard ⋮ Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard ⋮ Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard ⋮ Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard ⋮ New insights into adaptive enrichment designs ⋮ Adaptive dose‐response studies to establish proof‐of‐concept in learning‐phase clinical trials ⋮ Optimization of adaptive designs with respect to a performance score ⋮ Adaptive designs with arbitrary dependence structure based on Fisher's combination test ⋮ Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes ⋮ Adaptive choice of scale tests in flexible two-stage designs with applications in experimental ecology and clinical trials ⋮ Basic concepts of multiple tests -- a survey ⋮ A prospective combination of phase II and phase III in drug development ⋮ Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations ⋮ Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials ⋮ Interim Design Modifications in Time-to-Event Studies ⋮ Probabilistic Foundation of Confirmatory Adaptive Designs ⋮ Estimation following selection of the largest of two normal means ⋮ Development of Adaptive Group Sequential Procedure for Changing Sample Size ⋮ Confidence intervals for confirmatory adaptive two‐stage designs with treatment selection ⋮ Partition testing in confirmatory adaptive designs with structured objectives ⋮ Robustness of sample size re-estimation with interim binary data for double-blind clinical trials ⋮ Adaptive Sample Size Calculations in Group Sequential Trials ⋮ Interim Analysis and Sample Size Reassessment ⋮ A note on change point estimation in dose-response trials ⋮ On the efficiency of adaptive designs for flexible interim decisions in clinical trials ⋮ On design and inference for two-stage adaptive clinical trials with dependent data ⋮ Blinded sample size recalculation in multicentre trials with normally distributed outcome ⋮ Internal pilots for observational studies ⋮ Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs ⋮ An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs ⋮ Sample size reassessment for a two-stage design controlling the false discovery rate ⋮ Sequential Methods in Multi-Arm Clinical Trials ⋮ p-Value calculation for multi-stage additive tests ⋮ Analysis of ``learn-as-you-go (LAGO) studies ⋮ Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang ⋮ Monitoring Continuous Long-Term Outcomes in Adaptive Designs ⋮ Likelihood inference for a two-stage design with treatment selection ⋮ On Sample Size and Inference for Two‐Stage Adaptive Designs ⋮ Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches ⋮ Monitoring Clinical Trials with Multiple Arms ⋮ Sequential Tests for Noninferiority and Superiority ⋮ Inference of non-centrality parameter of a truncated non-central chi-squared distribution ⋮ Adaptive Multivariate Global Testing ⋮ Exact Confidence Bounds Following Adaptive Group Sequential Tests ⋮ Procedures for testing multiple endpoints in clinical trials: an overview ⋮ An Approach to the Conditional Error Rate Principle with Nuisance Parameters ⋮ Basic concepts of group sequential and adaptive group sequential test procedures ⋮ Adaptive Design for Censored Survival Data Adjusting for Covariates ⋮ A modified combination test for the analysis of a clinical trial when a protocol amendment changed the inclusion criteria ⋮ Are Flexible Designs Sound? ⋮ Adaptive designs with arbitrary dependence structure ⋮ A comparison of methods for constructing confidence intervals after phase II/III clinical trials ⋮ THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL ⋮ Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications ⋮ Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account
